Pfizer Covid Vaccine Partner BioNTech's Stock Is Rising After Earnings Beat
BioNTech stock has dropped 36% this year as demand fell for its Covid-19 vaccines produced with Pfizer.
Stay updated with breaking news from Biontech Se. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BioNTech stock has dropped 36% this year as demand fell for its Covid-19 vaccines produced with Pfizer.
By Helena Smolak BioNTech warned that full-year revenue from Covid-19 vaccines would be weaker than previously expected and reduced its spending plans. The...
Pfizer and BioNTech said an early trial of a combined Covid-19 and influenza vaccine had produced positive data. The companies are set for a race with...
Pfizer, Moderna and Novavax believe combination shots will simplify the process for people to protect themselves against Covid and the flu.
MAINZ, Germany, October 23, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the...